Cure Pharmaceutical Holding Corp.
SEC CIK 1643301 · CURR · last insider filing 2023-08-25
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Salkind Gene Z | Director | filed 2019 - 2023 |
| Costantino Robert J | Director | filed 2022 - 2023 |
| Davidson Robert Steven | Director · Chief Executive Officer | filed 2018 - 2023 |
| Bagg Gerald | Director | filed 2022 - 2023 |
| Duitch Nancy | Director · Chief Strategy Officer | filed 2020 - 2021 |
| Yuan William | Director | filed 2018 - 2021 |
| Bell John K | Director | filed 2019 - 2021 |
| King-Shaw Ruben JR | Director | filed 2019 - 2021 |
| Held Joshua | Director | filed 2021 - 2021 |
| Chung Lauren | Director | filed 2021 - 2021 |
| Goldin Anna | Director | filed 2021 - 2021 |
| Einstein Alan | Director | filed 2018 - 2018 |
| Berman Charles | Director | filed 2018 - 2018 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Bennett Joel M | CFO,CAO, Treasurer & Secretary | filed 2022 - 2022 |
| Berlent Jonathan | Chief Business Officer | filed 2020 - 2021 |
| Udell Mark | Chief Financial Officer | filed 2018 - 2021 |
| Redard Michael | Chief Financial Officer | filed 2019 - 2019 |
| Katz Alex | CFO | filed 2019 - 2019 |
| Rousset Jessica | Chief Operating Officer | filed 2018 - 2018 |
| Maliski Edward | Chief Science Officer | filed 2018 - 2018 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.